Survey of monoclonal antibody disposition in man utilizing a minimal physiologically-based pharmacokinetic model

被引:36
作者
Cao, Yanguang [1 ]
Jusko, William J. [1 ]
机构
[1] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Buffalo, NY 14214 USA
基金
美国国家卫生研究院;
关键词
PBPK; Minimal PBPK models; Monoclonal antibody; Distribution; INTERSTITIAL EXCLUSION; PBPK MODEL; IGG; THERAPEUTICS; VOLUME; MUSCLE;
D O I
10.1007/s10928-014-9374-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Minimal physiologically based pharmacokinetic (mPBPK) models provide a simple and sensible approach that incorporates physiological elements into pharmacokinetic (PK) analysis when only plasma data are available. With this modeling concept, a second-generation mPBPK model was further developed with specific accommodations for the unique PK properties of monoclonal antibodies (mAb). This study applied this model to extensively survey mAb PK in man in order to seek general perspectives on mAb distributional and elimination features. Profiles for 72 antibodies were successfully analyzed with this model. The model results provide assessment regarding: (1) predominant clearance site, in plasma or interstitial fluid (ISF); (2) mAb ISF concentrations in two groups of lumped tissues with continuous (V (tight) ) or fenestrated (V (leaky) ) vascular endothelium; (3) Transcapillary escape rate (TER), an indicator of systemic vascular permeability. For 93 % of surveyed mAbs, the model assuming clearance from plasma (CL (p) ) produced better or at least equivalent model performance than the model with clearance from ISF and yielded most consistent values of vascular reflection coefficients (sigma(1) and sigma(2)) among all antibodies. The average mAb ISF concentration in V (tight) and V (leaky) at equilibrium was predicted to be about 6.8 and 37.9 % of that in plasma. A positive correlation was detected between plasma clearance and TER among most mAbs, which could be interpreted as both parameters having common determinants related to ISF tissue distribution in this model context. The mAbs with relative higher plasma clearance (> 0.035 L/h/70 kg) did not reveal such positive correlation between clearance and TER, implying that the factors contributing to high clearance may not necessarily increase tissue distribution and penetration. In conclusion, this mPBPK model offers a more mechanistic approach for analyzing plasma mAb PK than compartment models and generates parameters providing useful intrinsic distributional and elimination insights for a large number of mAbs that were examined in man.
引用
收藏
页码:571 / 580
页数:10
相关论文
共 25 条
  • [1] Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics
    Boswell, C. Andrew
    Tesar, Devin B.
    Mukhyala, Kiran
    Theil, Frank-Peter
    Fielder, Paul J.
    Khawli, Leslie A.
    [J]. BIOCONJUGATE CHEMISTRY, 2010, 21 (12) : 2153 - 2163
  • [2] Physiochemical and Biochemical Factors Influencing the Pharmacokinetics of Antibody Therapeutics
    Bumbaca, Daniela
    Boswell, C. Andrew
    Fielder, Paul J.
    Khawli, Leslie A.
    [J]. AAPS JOURNAL, 2012, 14 (03): : 554 - 558
  • [3] Incorporating target-mediated drug disposition in a minimal physiologically-based pharmacokinetic model for monoclonal antibodies
    Cao, Yanguang
    Jusko, William J.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 (04) : 375 - 387
  • [4] Second-generation minimal physiologically-based pharmacokinetic model for monoclonal antibodies
    Cao, Yanguang
    Balthasar, Joseph P.
    Jusko, William J.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 (05) : 597 - 607
  • [5] Applications of minimal physiologically-based pharmacokinetic models
    Cao, Yanguang
    Jusko, William J.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2012, 39 (06) : 711 - 723
  • [6] Therapeutic antibodies for autoimmunity and inflammation
    Chan, Andrew C.
    Carter, Paul J.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2010, 10 (05) : 301 - 316
  • [7] D'Argenio DZ, 2009, ADAPT V USERS GUIDE
  • [8] PHYSIOLOGICAL-PARAMETERS IN LABORATORY-ANIMALS AND HUMANS
    DAVIES, B
    MORRIS, T
    [J]. PHARMACEUTICAL RESEARCH, 1993, 10 (07) : 1093 - 1095
  • [9] MEDIATION OF PINOCYTOSIS IN CULTURED ARTERIAL SMOOTH-MUSCLE AND ENDOTHELIAL CELLS BY PLATELET-DERIVED GROWTH-FACTOR
    DAVIES, PF
    ROSS, R
    [J]. JOURNAL OF CELL BIOLOGY, 1978, 79 (03) : 663 - 671
  • [10] Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice
    Garg A.
    Balthasar J.P.
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2007, 34 (5) : 687 - 709